Physician profile
Michael S Cicchetti
NPI 1164644183
$36,140.98
in general payments reported to CMS, 2019-2025
37 companies · $15K in 2025
The $15K reported for 2025 was more than what 99% of Physical Medicine & Rehabilitation providers received nationally (typical 2025 total: $138).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $450 · 2020: $985 · 2021: $4,184 · 2022: $3,549 · 2023: $2,733 · 2024: $8,897 · 2025: $15K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $10K · Food and Beverage: $9,893 · Consulting Fee: $7,014.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $10,066.03 |
| Food and Beverage | $9,893.33 |
| Consulting Fee | $7,014.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Spr Therapeutics, INC | $14,826.11 | 2022-2025 | Sprint Pns System |
| Abbott Laboratories | $9,200.75 | 2021-2025 | Proclaim, Octrode, Axium |
| Nevro Corp. | $1,811.79 | 2020-2024 | Senza |
| Si-Bone, INC. | $1,615.42 | 2019-2025 | |
| Saluda Medical Americas, INC. | $1,315.55 | 2023-2025 | Evoke, Evoke Scs |
| Spinal Simplicity, LLC | $1,248.41 | 2024 | Ha Minuteman G3-R, Liberty Si |
| Nalu Medical, INC. | $1,189.88 | 2024 | Nalu Neurostimulation System |
| Boston Scientific Corporation | $820.07 | 2019-2025 | Wavewriter Alpha Prime 16 |
| Vertos Medical, INC. | $718.63 | 2023-2024 | Mild Device Kit |
| Abbvie INC. | $553.15 | 2021-2025 | Botox, Ubrelvy |
| Curonix LLC | $550.16 | 2024 | Pns Freedom-4a Permanent Neurostimulator Receiver Kit Channel A |
| Painteq LLC | $328.60 | 2023-2024 | Painteq |
| Merz Pharmaceuticals, LLC | $267.05 | 2021-2025 | Xeomin |
| Allergan, INC. | $214.42 | 2019-2020 | |
| Relievant Medsystems, INC. | $174.36 | 2021 |
Show all 37 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $146.37 | 2024 | Mild Device Kit |
| Ipsen Biopharmaceuticals, INC | $127.44 | 2020-2024 | Dysport |
| Avanos Medical | $116.64 | 2019-2025 | |
| Merz North America, INC. | $89.85 | 2019-2020 | |
| Foundation Fusion Solutions, LLC | $83.50 | 2024 | |
| Medtronic, INC. | $77.20 | 2022-2024 | Intellis Adaptivestim |
| Fidia Pharma USA INC. | $74.37 | 2023-2024 | Triluron, Hymovis, Hyalgan |
| Pacira Therapeutics, INC. | $73.61 | 2019-2020 | |
| Bioventus LLC | $67.28 | 2022-2024 | Durolane |
| Revance Therapeutics, INC. | $60.34 | 2024 | Daxxify |
| Scilex Pharmaceuticals INC. | $58.25 | 2019-2025 | |
| Celularity INC. | $54.00 | 2019 | |
| Zyla Life Sciences, INC. | $52.05 | 2019-2020 | |
| Depuy Synthes Sales INC. | $46.52 | 2020 | |
| Vertex Pharmaceuticals Incorporated | $33.70 | 2025 | |
| Ferring Pharmaceuticals INC. | $27.43 | 2019-2020 | |
| Xeris Pharmaceuticals, INC. | $22.08 | 2024 | Keveyis |
| Pacira Pharmaceuticals Incorporated | $21.73 | 2023 | Zilretta, Iovera |
| Assertio Therapeutics, INC. | $19.70 | 2020 | |
| Botanix Sb INC | $19.27 | 2025 | Sofdra |
| Amgen INC. | $18.49 | 2023 | Prolia, Evenity |
| Pfizer INC. | $16.81 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Cicchetti listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.